Recherche
-
Determinants of therapeutic lag in multiple sclerosis
(Multiple Sclerosis Journal. vol. 27, n° 12, pp. 1838-1851, 2021-10)Article de revueLibre accès -
Olfaction and anosmia: From ancient times to COVID-19
(Journal of the Neurological Sciences. vol. 425, 2021-06-15)Article de revueLibre accès -
Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder
(Autism Research. vol. 14, n° 9, pp. 1854-1872, 2021-09)Article de revueLibre accès -
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueLibre accès -
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome
(Annales d'Endocrinologie. vol. 83, n° 2, pp. 119-141, 2022-04)Article de revue -
Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
(Science Advances. vol. 8, n° 30, 2022-07-29)Article de revueLibre accès -
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
(Frontiers in Psychiatry. vol. 9, pp. 326, 2018)Article de revueLibre accès -
Insulin modulates emotional behavior through a serotonin-dependent mechanism
(Molecular Psychiatry, 2022-10-07)Article de revue -
Functional heterogeneity of POMC neurons relies on mTORC1 signaling
(Cell Reports. vol. 37, n° 2, 2021-10-12)Article de revueLibre accès -
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
(JAMA neurology. vol. 81, n° 3, pp. 273-282, 2024-03-01)Article de revueLibre accès